Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Arcutis Biotherapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in developing and marketing innovative topical and systemic treatments for immune-mediated dermatological diseases. Its core products include ZORYVE, a portfolio of PDE4 inhibitor creams and foams approved for plaque psoriasis, atopic dermatitis, and seborrheic dermatitis. Arcutis targets dermatologists, primary care providers, and pediatricians, leveraging proprietary formulations and a focused development platform to address unmet needs in chronic skin conditions.
This description was generated via AI from an annual report. Updated about 1 year ago.